Home › Funds › FOLKETRYGDFONDET › GMAB
FOLKETRYGDFONDET position in GMAB
GENMAB A/S · Health Care
FOLKETRYGDFONDET reported holding 165,082 shares of GMAB (GENMAB A/S) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 0.11% of its reported portfolio and ranking #10 among its reported holdings. FOLKETRYGDFONDET has disclosed GMAB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How FOLKETRYGDFONDET's GMAB position evolved
FOLKETRYGDFONDET first disclosed a stake in GMAB in Q3 2023 at 170,385 shares (US$6.0M). Across 13 filings, FOLKETRYGDFONDET increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 165,082 shares valued at US$5.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 170.38K | $6.01M | New |
| Q4 2023 | 170.38K | $5.43M | Hold |
| Q1 2024 | 170.38K | $5.10M | Hold |
| Q2 2024 | 170.38K | $4.28M | Hold |
| Q3 2024 | 170.38K | $4.15M | Hold |
| Q4 2024 | 170.38K | $3.56M | Hold |
| Q1 2025 | 170.38K | $3.34M | Hold |
| Q2 2025 | 172.80K | $3.57M | Add |
| Q3 2025 | 174.81K | $5.36M | Add |
| Q4 2025 | 174.81K | $5.38M | Hold |
| Q1 2026 | 160.77K | $4.31M | Reduce |
| Q2 2026 | 165.08K | $4.53M | Add |
| Q3 2026 | 165.08K | $5.89M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 35 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$360.8M), Orbis Allan Gray Ltd (US$312.3M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 13.13M sh · $360.77M · Q2 2026
- Orbis Allan Gray Ltd 11.37M sh · $312.28M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 6.87M sh · $188.58M · Q2 2026
- Sofinnova Investments, Inc. 4.05M sh · $111.12M · Q2 2026
- HARDING LOEVNER LP 3.09M sh · $86.90M · Q2 2026
- Deep Track Capital, LP 3.00M sh · $82.41M · Q2 2026
- Dixon Mitchell Investment Counsel Inc. 407.00K sh · $14.52M · Q3 2026
More on FOLKETRYGDFONDET
FAQ
How long has FOLKETRYGDFONDET held GMAB?
FOLKETRYGDFONDET has disclosed GMAB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is FOLKETRYGDFONDET's current position in GMAB?
As of Q3 2026, FOLKETRYGDFONDET holds 165.08K shares of GMAB (GENMAB A/S), valued at $5.89M, representing 0.11% of its reported portfolio and ranking #10.
Has FOLKETRYGDFONDET been buying or selling GMAB?
In the latest 13F filing (Q3 2026), FOLKETRYGDFONDET held unchanged its position in GMAB.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.